The Clorox Company (CLX) is scheduled to go
ex-dividend and has announced a new quarterly dividend of
$1.24 per share, a fact of potential interest to investors. Several recent investment changes were made, with a notable increase by
Callan Family Office LLC and
Cwm LLC, while other firms like Atria Wealth Solutions and BNP Paribas Exane have trimmed their holdings. CLX’s consistent demand has led to dividend growth, despite a price target cut by
JPMorgan, citing slowing demand but reckoning the company's dividend perseverance. On the financial front,
Clorox’s Q4 and FY25 earnings have been revealed, and the company’s
FY26 outlook was discussed in a November 3rd webcast. The company’s consistent
dividend history made it appealing as a defensive play, despite some investment reductions by certain management holdings.
JP Morgan and B of A Securities both maintained a neutral stance on Clorox. Jim Cramer’s shared that the company might make a good investment, regardless of a recent 12% stock drop. Furthermore, with
Q3 2025 earnings call highlights showing resilient margins amid a challenging market, analysts consider The Clorox Company a growing dividend stock with low PE ratios. Lastly, the company just declared a regular quarterly dividend of $1.22 per share, and an updated Q3 fiscal year 2025 results.
Clorox Company CLX News Analytics from Tue, 28 Jan 2025 08:00:00 GMT to Sat, 18 Oct 2025 13:54:41 GMT -
Rating 2
- Innovation -2
- Information 5
- Rumor -3
